| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Guest Access | Sign In via User Name/Password
|
|
|
|||||||
Guest Access | Sign In via User Name/Password |
|||||||||
1 From the Fondazione Clinica del Lavoro di Pavia, Gussago Medical Center (BS), Italy
2 From Veruno Medical Center (NO), Italy
3 From the Royal Brompton National Heart and Lung Hospital, London, England
To evaluate possible autonomic nervous system (ANS) dysfunction in patients with chronic obstructive pulmonary disease (COPD) in the absence of any hypoxic neuronal damage, we studied 31 patients with COPD patients aged 31 to 68 years (55±10) and 32 age-matched healthy subjects (control). Respiratory function in the patients was as follows: FEV1=52±8 percent; PaO2= 71±14 mm Hg; and PaCO2=40±10 mm Hg. The ANS was assessed by heart rate variability (HRV) in the time domain (SD of mean RR interval) and frequency domain (autoregressive spectral analysis recognizing low [LF] and high [HF] frequency components, vagal and sympathetic related, respectively). Patients and controls were evaluated at rest and during vagal (controlled breathing [CB]) and sympathetic (passive head-up tilt) maneuvers. Patients with COPD showed a depressed global HRV (rest SD=34±20 ms vs 45±15 ms, p<0.05; tilt SD=28±14 ms vs 38±13, p<0.01) with a predominant respiratory drive (rest HF=44±28 vs 28±18, p<0.05; tilt HF 42±28 vs 16±12, p<0.01) as compared with normal subjects. In the control group, vagal and sympathetic responses were in opposite directions following a stimulus, whereas there was no significant HRV response in the COPD group. We conclude that patients with COPD have abnormalities of ANS function, with in particular a depressed HRV response to sympathetic and vagal stimuli.
Key Words: autonomic nervous system • COPD • heart rate variability • power spectral analysis
Submitted on October 25, 1993
Accepted on March 7, 1994
This article has been cited by other articles:
|
|
 |
|
  S. Andreas, S. D. Anker, P. D. Scanlon, and V. K. Somers Neurohumoral Activation as a Link to Systemic Manifestations of Chronic Lung Disease Chest, November 1, 2005; 128(5): 3618 - 3624. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Pichon, C. de Bisschop, V. Diaz, and A. Denjean Parasympathetic Airway Response and Heart Rate Variability Before and at the End of Methacholine Challenge Chest, January 1, 2005; 127(1): 23 - 29. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. W. Raymond Vagal Pas de Deux: Heart-Lung Interplay in Postexercise Heart Rate Recovery Chest, April 1, 2004; 125(4): 1186 - 1190. [Full Text] [PDF]
|
|
|
|
|
|
N. Seshadri, T. R. Gildea, K. McCarthy, C. Pothier, M. S. Kavuru, and M. S. Lauer Association of an Abnormal Exercise Heart Rate Recovery With Pulmonary Function Abnormalities Chest, April 1, 2004; 125(4): 1286 - 1291. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Costes, F. Roche, V. Pichot, J.M. Vergnon, M. Garet, and J-C. Barthelemy Influence of exercise training on cardiac baroreflex sensitivity in patients with COPD Eur. Respir. J., March 1, 2004; 23(3): 396 - 401. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. N. Bartels, S. Jelic, P. Ngai, R. C. Basner, and R. E. DeMeersman High-Frequency Modulation of Heart Rate Variability During Exercise in Patients With COPD Chest, September 1, 2003; 124(3): 863 - 869. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D M Mannino, A S Buist, T L Petty, P L Enright, and S C Redd Lung function and mortality in the United States: data from the First National Health and Nutrition Examination Survey follow up study Thorax, May 1, 2003; 58(5): 388 - 393. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Yildiz, T. Tukek, V. Akkaya, A. B. Sozen, A. Yildiz, F. Korkut, and V. Yilmaz Ventricular Arrhythmias in Patients With COPD Are Associated With QT Dispersion Chest, December 1, 2002; 122(6): 2055 - 2061. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. HEINDL, M. LEHNERT, C.-P. CRIEE, G. HASENFUSS, and S. ANDREAS Marked Sympathetic Activation in Patients with Chronic Respiratory Failure Am. J. Respir. Crit. Care Med., August 15, 2001; 164(4): 597 - 601. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. N. Bartels, J. M. Gonzalez, W. Kim, and R. E. De Meersman Oxygen Supplementation and Cardiac-Autonomic Modulation in COPD Chest, September 1, 2000; 118(3): 691 - 696. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Sakamaki, T. Satoh, N. Nagaya, S. Kyotani, N. Nakanishi, and Y. Ishida Abnormality of Left Ventricular Sympathetic Nervous Function Assessed by 123I-Metaiodobenzylguanidine Imaging in Patients With COPD* Chest, December 1, 1999; 116(6): 1575 - 1581. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Ponikowski, M. Piepoli, T.P. Chua, W. Banasiak, D. Francis, S.D. Anker, and A.J.S. Coats The impact of cachexia on cardiorespiratory reflex control in chronic heart failure Eur. Heart J., November 2, 1999; 20(22): 1667 - 1675. [Abstract] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
